BGM Pharmaceuticals is a 100% black owned, BBBEE Level 1 Biotechnology Firm founded in 2013 by Dr. Blaine and Mr. Godfrey Mark Bloy. The company was built with the vision of providing affordable, innovative medicines to the African continent. Our portfolio of products and healthcare technologies are carefully selected to meet the health-related needs of Healthcare Practitioners and Patients on the African continent. BGM Pharmaceuticals is committed to continuous improvements & advancements in the field of modern medicine by ensuring we keep our core values at the heart of what we do.
There is no investment information
No recent news or press coverage available for BGM Pharmaceuticals.